BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/15/2016 10:30:00 AM | Browse: 1363 | Download: 2259
 |
Received |
|
2016-04-29 09:29 |
 |
Peer-Review Started |
|
2016-05-02 16:09 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2016-05-30 15:02 |
 |
Revised |
|
2016-06-09 16:17 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2016-06-23 17:29 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2016-07-06 18:57 |
 |
Articles in Press |
|
2016-07-06 18:57 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2016-08-05 15:47 |
 |
Publish the Manuscript Online |
|
2016-08-15 10:30 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chiara Caparello, Laura L Meijer, Ingrid Garajova, Alfredo Falcone, Tessa Y Le Large, Niccola Funel, Geert Kazemier, Godefridus J Peters, Enrico Vasile and Elisa Giovannetti |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Istituto Toscano Tumori ITT-2011 |
|
| Regione Toscana “Fas Salute” |
to Funel N and Giovannetti E |
| Bennink Foundation |
|
| CCA Foundation |
to Giovannetti E |
| AIRC/Start-Up |
to Giovannetti E |
|
| Corresponding Author |
Dr. Elisa Giovannetti, Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, via Paradisa, 2, 56124 Pisa, Italy. elisa.giovannetti@gmail.com |
| Key Words |
FOLFIRINOX; Personalized therapy; New treatments; MicroRNA; Pancreatic cancer |
| Core Tip |
The present manuscript is a review of the state of the art treatments, focusing on biomarkers, target therapies and future perspectives in order to develop personalized treatments. |
| Publish Date |
2016-08-15 10:30 |
| Citation |
Caparello C, Meijer LL, Garajova I, Falcone A, Le Large TY, Funel N, Kazemier G, Peters GJ, Vasile E, Giovannetti E. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer. World J Gastroenterol 2016; 22(31): 6987-7005 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i31/6987.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i31.6987 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.